Trial intelligence / Profile preview

Oxytocin versus oxytocin + propranolol for labor progression

IRCT2016092629983N1Phase 3Completed

Sponsor
Gorgan Congenital Malformations Research Center
Start
Oct 2016
Modality
Small Molecules, Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Phase 3 trial of oxytocin and propranolol in Labor Induction and Augmentation (2 arms), sponsored by Gorgan Congenital Malformations Research Center. Started Oct 2016; status: completed.

02

Drugs

oxytocinpropranolol
03

Conditions

Labor Induction and Augmentation

Beyond the preview

Go deeper on IRCT2016092629983N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016092629983N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call